Trial of Vemurafenib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
This study is not yet open for participant recruitment.
Verified April 2012 by Melanoma Research Foundation Breakthrough Consortium
Sponsor:
Melanoma Research Foundation Breakthrough Consortium
Collaborator:
Genentech
Information provided by (Responsible Party):
Melanoma Research Foundation Breakthrough Consortium
ClinicalTrials.gov Identifier:
NCT01495988
First received: December 9, 2011
Last updated: April 18, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | March 2015 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |